Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibacterial
    (2)
  • Antibiotic
    (2)
  • Others
    (3)
Filter
Search Result
Results for "

neutropenia

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    6
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    2
    TargetMol | Compound_Libraries
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Recombinant Protein
    3
    TargetMol | Recombinant_Protein
Meropenem
SM 7338
T022496036-03-2
Meropenem (SM 7338) is a broad-spectrum carbapenem antibiotic administered intravenously for severe bacterial infections caused by sensitive agents. It commonly causes mild, transient aminotransferase elevations and can rarely lead to clinically apparent cholestatic liver injury.
  • $42
In Stock
Size
QTY
Meropenem trihydrate
SM 7338 trihydrate
T12004119478-56-7
Meropenem trihydrate (SM 7338 trihydrate) is a carbapenem antibiotic with broad-spectrum antibacterial activity.
  • $39
In Stock
Size
QTY
Balapiravir
R1626,Ro 4588161
T14493690270-29-2
Balapiravir (R1626, Ro 4588161) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479). IC50 Value: Target: HCV Balapiravir was discontinued for safety reasons in 28-36% of patients (m
  • $112
5 days
Size
QTY
LasR-IN-2
T61581
LasR-IN-2, a compound that inhibits the activity of LasR, forms hydrogen bonding with the TRY-56 residue. It finds application in the study of bacterial infection, neutropenia, severe burns, and chronic lung disease in cystic fibrosis (CF) [1].
  • $1,520
10-14 weeks
Size
QTY
Thenalidine tartrate
T695162784-55-6
Thenalidine is an antihistamine with anticholinergic properties used as an antipruritic drug. It was withdrawn from the US, Canadian, and UK markets due to a risk of neutropenia. Thenalidine is an antagonist of the H1-receptor.
  • $1,520
6-8 weeks
Size
QTY
Eflapegrastim
T771721384099-30-2
Eflapegrastim, a humanized IgG4 monoclonal antibody and granulocyte colony-stimulating factor (G-CSF), targets the G-CSF receptor (c-Fms). It promotes the proliferation and differentiation of neutrophil progenitor cells, ensuring a stable count of mature and functional neutrophils, and effectively shortens the duration of neutropenia [1].
  • Inquiry Price
Size
QTY